Viewing Study NCT06045195


Ignite Creation Date: 2025-12-24 @ 1:40 PM
Ignite Modification Date: 2026-01-01 @ 4:32 AM
Study NCT ID: NCT06045195
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-04-06
First Post: 2023-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma
Sponsor: University of Cologne
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module